Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sinovac Biotech Company Profile (NYSE:SVA)

Consensus Ratings for Sinovac Biotech (NYSE:SVA) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $9.00 (61.58% upside)

Analysts' Ratings History for Sinovac Biotech (NYSE:SVA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/27/2014Morgan StanleyReiterated RatingOverweight$9.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/21/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
3/20/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/20/2014Morgan StanleyUpgradeEqual Weight -> Overweight$6.50 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2014AegisReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
11/13/2013AegisReiterated RatingBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
8/16/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
8/15/2013AegisUpgradeHold -> Buy$4.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
3/15/2013AegisReiterated RatingHold$4.00ViewTweet This Rating  Share This Rating on StockTwits
12/12/2012AegisInitiated CoverageHold$2.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)